Norethisterone acetate alters coagulation gene expression in vitro in human cell culture

Thrombosis Research

Volumn 131, Issue 1, 2013, Pages 72-77

  Brosnan, Jeanette F ^a   Sheppard, Brian L ^a   Kelly, L A ^a   O'Leary, John J ^a   Norris, Lucy A ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

17 estradiol; Coagulation; Menopause; Progestin; Thrombosis

Indexed keywords

2 HYDROXYESTRADIOL; BLOOD CLOTTING FACTOR 7; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; FIBRINOGEN; GESTAGEN; MESSENGER RNA; NORETHISTERONE ACETATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOSIS; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

BLOOD COAGULATION; CELLS, CULTURED; CONTRACEPTIVES, ORAL, SYNTHETIC; ESTRADIOL; ESTRONE; FACTOR VII; FIBRINOGEN; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS; NORETHINDRONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84871660267     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.09.006     Document Type: Article

References (41)

1. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333 (Pubitemid 34761611)
2. V. Olie, M. Canonico, and P.Y. Scarabin Post menopausal hormone therapy and venous thromboembolism Thromb Res 127 Suppl. 3 2011 S26 S29
3. Mitchell Harman Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in post menopausal women starting treatment within 10 years of the menopause Evid Based Med 15 2010 69 70
4. G. Rosanna, C. Vitale, I. Spoletini, and M. Fini Cardiovascular health in the post menopausal woman: impact of the timing of hormone replacement therapy Climacteric 2012 1 7 [Early Online]
5. M. Canonico, A. Fournier, L. Carcaillon, V. Olie, G. Plu-Bureau, and E. Oger Post menopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort study Arterioscler Thromb Vasc Biol 30 2010 340 345
6. J.F. Brosnan, B.L. Sheppard, and L.A. Norris Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration? Thromb Haemost 97 2007 558 565 (Pubitemid 46592933)
7. P.Y. Scarabin, H.C. Hemker, C. Clement, V. Soisson, and M. Alhenc-Gelas Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens Menopause 18 8 2011 873 879
8. M. Canonico, M. Alhenc-Gelas, G. Plu-Bureae, V. Olie, and P.Y. Scarabin Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen Menopause 17 6 2010 1122 1127
9. A.E.A. Dahm, A.L. Eilertson, J. Goeman, O.K. Olstad, R. O;vstebø, and P. Kierulf A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy post menopausal women Thromb Res 2012 10.1016/j.thrombres.2011.12.009
10. L.A. Kelly, J.J. O'Leary, D. Seidlova-Wuttke, W. Wuttke, and L.A. Norris Genistein alters coagulation gene expression in ovarectomised rats treated with phytoestrogens Thromb Haemost 104 2010 1250 1257
11. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, and H. Levesque Hormone therapy and venous thromboembolism among post menopausal women: impact of route of estrogen administration and progestogens: the ESTHER study Circulation 115 2007 840 845 (Pubitemid 46294724)
12. A. Nath, and R. Sitruk-Ware Different cardiovascular effects of progestins according to structure and activity Climacteric 12 Suppl. 1 2009 96 101
13. D.E. Masood, E.C. Roach, K.G. Beauregard, and R.A. Khalib Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease Curr Drug Metab 11 8 2010 693 714
14. K.K. Koh, and B.-K. Yoon Controversies regarding hormone therapy: Insights from inflammation and hemostasis Cardiovasc Res 70 1 2006 22 30
15. M.S. Post, M. Christella, L.G.D. Thomassen, M.J. van der Mooren, W. Marchien van Baal, and J. Rosing Effect of oral and transdermal estrogen replacement therapy hemostatic variables associated with venous thrombosis a randomised, placebo controlled study in post menopausal women Arterioscler Thromb Vasc Biol 23 2003 1116 1121 (Pubitemid 36713570)
16. C.N. Bagot, M.S. Marsh, M. Whitehead, R. Sherwood, L. Roberts, and R.K. Patel The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy J Thromb Haemost 8 2010 1736 1744
17. G.D. Lowe, M.N. Upton, A. Rumley, A. McConnachie, D.S. O'Reilly, and G.C. Watt Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, tPA, PAI and C-reactive protein- a cross sectional population survey Thromb Haemost 86 2 2001 550 556 (Pubitemid 32743265)
18. S. Safe Transcriptional activation of genes by 17β-estradiol through estrogen receptor SP-1 interactions Vitam Horm 62 2001 231 252 (Pubitemid 33805706)
19. M. Canonico, G. Plu-Bureau, and P.Y. Scarabin Progestogens and venous thromboembolism among postmenopausal women using hormone therapy Maturitas 70 4 2011 354 360
20. L.A. Norris, and J. Bonnar The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives Br J Obstet Gynaecol 103 3 1996 Mar 261 267 (Pubitemid 26075461)
21. N.L. Smith, J.R. Wiley, C. Legault, K.M. Rice, S.R. Heckbert, and B.M. Psaty Effect of progestogen and progestogen type on haemostasis measures in post menopausal women: the post menopausal estrogen/progestin intervention (PEPI) study Menopause 15 6 2008 1145 1150
22. A.L. Cleuren, I. Postmus, H.L. Vos, P.H. Reitsma, and B.J.M. van Vlijmen Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue Thromb Res 128 2011 200 201
23. A.K. Roy, B. Chatterjee, K.V. Rao, C.V. Murty, F.H. Sarkar, and D. Majumder Androgen regulation of hepatic gene expression J Steroid Biochem 27 4-6 1987 1129 1134 (Pubitemid 18020182)
24. W.L. Kraus, and B.S. Katzenellenbogen Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists Endocrinology 132 6 1993 2371 2379 (Pubitemid 23156884)
25. G.E. Dressing, J.E. Goldberg, N.J. Charles, K.L. Schwertfeger, and C.A. Lange Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications Steroids 76 2011 11 17
26. D. Africander, N. Verhoog, and J.P. Hapgood Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception Steroids 76 2011 636 652
27. K.W. Nettles, and G.L. Greene Ligand control of coregulator recruitment to nuclear receptors Annu Rev Physiol 67 2005 309 333 (Pubitemid 40404494)
28. F. Schatz, E. Kuczynski, H.J. Kloosterbooer, L. Buchwalder, C. Tang, and G. Krikun Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial cells: Evidence of progestogenic effects Steroids 70 12 2005 840 845 (Pubitemid 41330987)
29. Y. Nagamine Transcriptional regulation of the plasminogen activator inhibitor type 1 with emphasis on negative regulation Thromb Haemost 100 6 2008 1007 1013
30. S. Gopal, S. Garibaldi, L. Goglia, K. Polak, G. Palla, and S. Spina Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) Mol Hum Reprod 2012 10.1093/molehr/gas011 [epub ahead of print]
31. M. Canonico, G. Plu-Bureau, G.D. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis BMJ 336 2008 1227 1231 (Pubitemid 351809317)
32. F. Laliberte, K. Dea, M.S. Duh, K.H. Kahler, M. Rolli, and P. Lefebvre Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy Menopause 18 10 2011 1052 1059
33. C.J. Lockwood, W. Murk, U.A. Kavisli, L.F. Buchwalder, S.T. Huang, and E.F. Funae Progestin and thrombin regulate tissue factor expression in human term decidual cells J Clin Endocrinol Metab 94 6 2009 2164 2170
34. S. Kato, M. Pinto, A. Carvajal, N. Espinoza, C. Monso, and A. Sadarangani Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75-1 J Clin Endocrinol Metab 90 2 2005 1181 1188 (Pubitemid 40279252)
35. M.S. Bajaj, J.J. Birktoft, S.A. Steer, and S.P. Bajaj Structure and biology of tissue factor pathway inhibitor Thromb Haemost 86 4 2001 959 972 (Pubitemid 32975818)
36. W.F. Novotny, T.J. Girard, J.P. Miletich, and G.J. Broze Jr. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma J Biol Chem 264 31 1989 18832 18837 (Pubitemid 19277636)
37. R.A. Shirk, Z. Zhang, and R.C. Winneker Differential effects of estrogens and progestogens on the anticoagulant tissue factor pathway inhibitor in the rat J Steroid Biochem Mol Biol 94 4 2005 361 368 (Pubitemid 40602476)
38. M. Zer-Fouineau, M. Jourdain, C. Boesch, M. Hecker, C. Bronner, and V.B. Schini-Kerth Certain progestins prevent the enhancing effect of 17β-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells Arterioscler Thromb Vasc Biol 29 2009 586 593
39. E. Stadberg, P. Westlund, B.-M. Landgren, A.-R. Aedo, S.Z. Cekan, and L.-A. Mattson Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple doses to post menopausal women Maturitas 33 1999 59 69 (Pubitemid 29469719)
40. L.L. Harison, and D. Harari Evaluation of the bioequivalence of two 7 day 17beta-estradiol transdermal delivery systems by anatomical site J Clin Pharmacol 42 2002 1134 1141
41. K.A. Steingold, W. Cefalu, W. Pardridge, H.L. Judd, and G. Chaudhuri Enhanced hepatic extraction of estrogens used for replacement therapy J Clin Endocrinol Metab 62 4 1986 761 766 (Pubitemid 16138151)